Publicacións (632) Publicacións nas que participase algún/ha investigador/a

2024

  1. A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinoma

    Frontiers in Immunology, Vol. 15

  2. Addressing the data bottleneck in medical deep learning models using a human-in-the-loop machine learning approach

    Neural Computing and Applications, Vol. 36, Núm. 5, pp. 2597-2616

  3. Biomarkers for Pre-Treatment Risk Stratification of Prostate Cancer Patients: A Systematic Review

    Cancers, Vol. 16, Núm. 7

  4. Cancer cell membrane-modified Soluplus® micelles for gemcitabine delivery to pancreatic cancer using a prodrug approach

    International Journal of Pharmaceutics, Vol. 662

  5. Controversies in prostate cancer management: Consensus recommendations from experts in northern Spain

    Actas Urologicas Espanolas

  6. Corrigendum to "Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients"

    Molecular & cellular proteomics : MCP

  7. Cost-Utility Analysis of Adjuvant Olaparib for Germline BRCA1/2-Mutated, High-Risk HER2-Negative Early Breast Cancer in Spain

    PharmacoEconomics - Open

  8. DNA methylation markers for oral cancer detection in non- and minimally invasive samples: a systematic review

    Clinical Epigenetics, Vol. 16, Núm. 1

  9. Enhancing patient outcomes: Integrating electronic cardiology consultation in primary care for cancer patients

    European Journal of Clinical Investigation, Vol. 54, Núm. 8

  10. Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management

    Scientific Reports, Vol. 14, Núm. 1

  11. Exercise-based cardio-oncology rehabilitation for cardiotoxicity prevention during breast cancer chemotherapy: The ONCORE randomized controlled trial

    Progress in Cardiovascular Diseases, Vol. 85, pp. 74-81

  12. Exploring Biginelli-based scaffolds as A2B adenosine receptor antagonists: Unveiling novel structure-activity relationship trends, lead compounds, and potent colorectal anticancer agents

    Biomedicine and Pharmacotherapy, Vol. 173

  13. First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN

    Breast Cancer Research and Treatment, Vol. 206, Núm. 2, pp. 317-328

  14. Genome-wide DNA methylation profiling in tongue squamous cell carcinoma

    Oral Diseases, Vol. 30, Núm. 2, pp. 259-271

  15. High-Throughput Mass Spectrometry Analysis of N-Glycans and Protein Markers after FUT8 Knockdown in the Syngeneic SW480/SW620 Colorectal Cancer Cell Model

    Journal of Proteome Research, Vol. 23, Núm. 4, pp. 1379-1398

  16. Implantable SDF-1α-loaded silk fibroin hyaluronic acid aerogel sponges as an instructive component of the glioblastoma ecosystem: Between chemoattraction and tumor shaping into resection cavities

    Acta Biomaterialia, Vol. 173, pp. 261-282

  17. Improvement of thrombosis management in patients with cancer: a practical consensus document of recommendations for cancer-associated thrombosis patients’ healthcare in Spain

    Clinical and Translational Oncology, Vol. 26, Núm. 6, pp. 1319-1328

  18. Improving quality of care by standardising patient data collection in electronic medical records in an oncology department in Spain

    BMJ Open Quality, Vol. 13, Núm. 2

  19. Indicators to evaluate quality of care in head and neck cancer in Spain

    Clinical and Translational Oncology, Vol. 26, Núm. 5, pp. 1089-1097

  20. Liquid Biopsies Based on Cell-Free DNA Integrity as a Biomarker for Cancer Diagnosis: A Meta-Analysis

    Diagnostics, Vol. 14, Núm. 14